FindTrial
Sign In

Evauation of a new tool for early detection of breast cancer

Evaluation of modified thermography as a tool for early detection of breast cancer in women attending breast clinic at NICPR

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/07/020450
Enrollment
500
Registered
2019-07-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Thermalytix screening: Thermalytix uses a series of deep learning models to pre-process 5 thermal images per subject, which then are passed to a feature extractor to extract 114 thermal

Sponsors

National Institute of Cancer Prevention and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women aged between 30 to 65 years attending breast clinic at NICPR will be included

Exclusion criteria

Exclusion criteria: 1. Pregnant women 2. Lactating women 3. Women diagnosed with breast cancer 4. Women not able to provide consent

Design outcomes

Primary

MeasureTime frame
Sensitivity, specificity, negative and positive predictive values of Thermalytix® with mammography and/or cytology/core biopsy as the gold standard verification testTimepoint: At the end of one year—

Secondary

MeasureTime frame
1. The agreement between the Thermalytix® and ultrasound/mammography diagnosis 2. Improvement in the PPV of CBE by Thermalytix® triaging Timepoint: At the end of one year—

Countries

India

Contacts

Public ContactDr Roopa Hariprasad

National Institute of Cancer Prevention and Research

roopaicmr@gmail.com09818278797

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026